EntraLogix Clinical Group Inc. Report issue

Academic/Hospital Phase 2
Founded: Newmarket Canada

Organization Overview

First Clinical Trial
2007
NCT00453271
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

nb-002 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Onychomycosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1